Ferramentas Pessoais
Você está aqui: Entrada Notícias David Andrews

David Andrews

HCP_EIS2018_DAndrews.jpg

 

 

 
David Andrews
Director of Pre-clinical Scientific Alliances, AstraZeneca

Dr David Andrews trained as a pharmacist at Nottingham University and then undertook PhD research in organic synthesis at Liverpool University. From 1990-2003, he held positions of increasing seniority in medicinal chemistry at GlaxoSmithKline. In 2003, he joined the Oncology iMed Chemistry Department of AstraZeneca where he led projects delivering the development candidates AZD4547, AZD9496 and AZD0364. Scientifically, David’s current main interests lie in Oncology, with around 60 publications and patents that span cancer and infection medicinal chemistry as well as synthetic chemistry and Open Innovation.  He is currently Director of Pre-clinical Scientific Alliances, accountable for a large portfolio of Discovery-phase project collaborations across Asia, EU and North America.

 

[voltar ao programa | back to the programme]